|
MCART1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.85399999983605E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.11470000025471E-07 |
| Normal-vs-Stage2 |
2.535700E-02 |
| Normal-vs-Stage3 |
4.21179999998689E-06 |
| Normal-vs-Stage4 |
1.376030E-03 |
| Stage1-vs-Stage2 |
1.295960E-01 |
| Stage1-vs-Stage3 |
6.994000E-01 |
| Stage1-vs-Stage4 |
4.938600E-01 |
| Stage2-vs-Stage3 |
1.205010E-01 |
| Stage2-vs-Stage4 |
5.127200E-01 |
| Stage3-vs-Stage4 |
3.814600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.81270000021838E-07 |
| Normal-vs-AfricanAmerican |
2.094200E-02 |
| Normal-vs-Asian |
1.52552999999056E-05 |
| Caucasian-vs-AfricanAmerican |
3.656200E-01 |
| Caucasian-vs-Asian |
3.577800E-01 |
| AfricanAmerican-vs-Asian |
1.276220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.999460E-04 |
| Normal-vs-Female |
5.27640000025364E-07 |
| Male-vs-Female |
4.134000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.95459999999359E-06 |
| Normal-vs-Age(41-60Yrs) |
8.59530000507647E-08 |
| Normal-vs-Age(61-80Yrs) |
5.760700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.825600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.879800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.214230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.623200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.898100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.000800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.651000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.078200E-01 |
| Classical-VS-Follicular |
6.189200E-01 |
| Classical-VS-Other |
1.940550E-01 |
| Classical-VS-Normal |
2.33029999996415E-06 |
| Tall-VS-Follicular |
4.158000E-01 |
| Tall-VS-Other |
3.706000E-01 |
| Tall-VS-Normal |
6.397800E-04 |
| Follicular-VS-Other |
2.128200E-01 |
| Follicular-VS-Normal |
1.662450E-03 |
| Other-VS-Normal |
3.578600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25289999999934E-06 |
| Normal-vs-N1 |
2.69409999997805E-06 |
| N0-vs-N1 |
2.175200E-01 |
|
|
